Aptevo Therapeutics hits near 1-mth high on positive leukemia drug trial data

Aptevo Therapeutics

26/05/2021 14:52

** Shares of biotechnology co  APVO.O  rise as much as 18.8%
to $30.0, their highest since late-April
    ** Co reports positive Phase-1 clinical data for its lead
leukemia drug candidate; drug showed limited side effects and
promising benefits for patients with relapsed, advanced stage
acute myeloid leukemia  urn:newsml:reuters.com:*:nACSdsLTja
    ** Stock set for its best day in six months, with trading
volumes nearly seven times their 30-day avg
    ** Shares down 31% YTD, as of last close 

 (Reporting by Ambar Warrick in Bengaluru)
 ((Ambar.Warrick@thomsonreuters.com; +91-80-6182-2837; Reuters
Messaging: ambar.warrick.thomsonreuters.com@reuters.net;
Twitter: @AmbarWarrick))